Copper Cu 64 Dotatate

DIAGNOSTIC_TEST2 trials

Conditions

Digestive System Neuroendocrine Tumor G1Digestive System Neuroendocrine Tumor G2Metastatic Digestive System Neuroendocrine NeoplasmMetastatic Malignant Neoplasm in the LiverNeuroendocrine TumorsPancreatic Neuroendocrine Tumor G1Pancreatic Neuroendocrine Tumor G2

Phase 4

Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors

RecruitingNCT06016855

Vanderbilt-Ingram Cancer CenterDigestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine Neoplasm +3

Start: 2024-05-31End: 2028-05-28Target: 6Updated: 2025-12-17

Unknown Phase

Copper Cu 64 Dotatate for the Detection, Localization and Monitoring of SSTR Expressing (NETs)

NCT04334837

Curium US LLCNeuroendocrine Tumors

Updated: 2020-10-09

Copper Cu 64 Dotatate

Sponsors

Conditions

Phase 4

Unknown Phase